We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
Cap. Flow
+$798M
Cap. Flow %
0.98%
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$65.3M
2
AMZN icon
Amazon
AMZN
+$50M
3
TSLA icon
Tesla
TSLA
+$30.5M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$26.6M
5
EPAM icon
EPAM Systems
EPAM
+$26.3M

Sector Composition

Rank Sector Weight
1 Technology 25.54%
2 Financials 13.15%
3 Healthcare 12.95%
4 Consumer Discretionary 12.27%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRNS
2576
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$426K ﹤0.01%
35,857
-925
-3% -$10.7K
PRVA icon
2577
Privia Health
PRVA
$2.87B
$425K ﹤0.01%
16,409
-724
-4% -$18K
ONTF
2578
DELISTED
ON24
ONTF
$424K ﹤0.01%
24,453
+709
+3% +$12.6K
DCPH
2579
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$423K ﹤0.01%
43,268
-1,035
-2% -$19.5K
NPKI
2580
NPK International
NPKI
$1.14B
$422K ﹤0.01%
143,606
+2,371
+2% +$7.61K
IIIV icon
2581
i3 Verticals
IIIV
$342M
$418K ﹤0.01%
18,333
-132
-0.7% -$2.96K
BLFY
2582
DELISTED
Blue Foundry Bancorp
BLFY
$415K ﹤0.01%
28,383
-93
-0.3% -$1.34K
HBMD
2583
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
$414K ﹤0.01%
19,000
+125
+0.7% +$2.67K
ALBO
2584
DELISTED
Albireo Pharma Inc
ALBO
$413K ﹤0.01%
17,754
-306
-2% -$8.14K
CRIS icon
2585
Curis
CRIS
$7.83M
$412K ﹤0.01%
216
-5
-2% -$11.9K
RLGT icon
2586
Radiant Logistics
RLGT
$395M
$412K ﹤0.01%
56,582
-102
-0.2% -$734
OFLX icon
2587
Omega Flex
OFLX
$312M
$410K ﹤0.01%
3,233
-54
-2% -$7.18K
TCS
2588
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$410K ﹤0.01%
2,741
-2
-0.1% -$338
LAB icon
2589
Standard BioTools
LAB
$314M
$409K ﹤0.01%
104,212
-1,315
-1% -$6.16K
AGTI
2590
DELISTED
Agiliti Inc
AGTI
$409K ﹤0.01%
17,678
-381
-2% -$8.35K
PCSB
2591
DELISTED
PCSB Financial Corporation
PCSB
$409K ﹤0.01%
21,487
-364
-2% -$6.82K
HFFG icon
2592
HF Foods Group
HFFG
$83.4M
$408K ﹤0.01%
48,254
-135
-0.3% -$996
KNSA icon
2593
Kiniksa Pharmaceuticals
KNSA
$5.93B
$408K ﹤0.01%
34,657
-812
-2% -$9.98K
GATO
2594
DELISTED
Gatos Silver, Inc.
GATO
$408K ﹤0.01%
39,271
+1,299
+3% +$15.6K
TSAT icon
2595
Telesat
TSAT
$897M
$407K ﹤0.01%
+14,196
New +$444K
RCKY icon
2596
Rocky Brands
RCKY
$369M
$404K ﹤0.01%
10,154
-24
-0.2% -$1.04K
CTOS icon
2597
Custom Truck One Source
CTOS
$2.37B
$403K ﹤0.01%
50,330
+7,020
+16% +$60.5K
CLSK icon
2598
CleanSpark
CLSK
$3.16B
$400K ﹤0.01%
42,059
-257
-0.6% -$4.11K
ULCC icon
2599
Frontier Group Holdings
ULCC
$1.7B
$399K ﹤0.01%
29,419
+766
+3% +$11.7K
HOFT icon
2600
Hooker Furnishings Corp
HOFT
$166M
$397K ﹤0.01%
17,073
+62
+0.4% +$1.56K

Similar funds

RhumbLine Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
  • RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
  • RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
  • RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
  • RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.

Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.